Autopsy report · NCT01056315

A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y

“Trial was stopped due to difficult enrolment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 1 year 2 months before it stopped.
• 553 participants enrolled.
• Results were posted on the registry 1 year 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Grünenthal GmbH

Sponsor type

Industry

Conditions

Painful Diabetic Neuropathy

Interventions

GRT3938Y; Placebo

Participants

553

Sites

61

Countries

United States

Trials that died the same way

• Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies
  “The trial was suspended due to the inability to enroll qualified participants” (79% match in meaning)
• Pancreatic Enzyme Supplementation for Celiac Disease
  “The trial was terminated prematurely by the sponsor for administrative reasons.” (76% match in meaning)
• A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults
  “The trial was terminated early due to regulatory constraints preventing the continuation of study conduct.” (75% match in meaning)
• Adverse Events of MRI With Abandoned Leads
  “The study was stopped due to challenges with recruitment and insufficient insurance coverage for the required procedures, which prevented continuation of the trial.” (75% match in meaning)
• Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
  “Trial stopped for futility” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.